Skip to Content

APO LMV 150 (Lamivudine 150 mg)

Pill imprint APO LMV 150 has been identified as Lamivudine 150 mg.

Lamivudine is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150 Front
Lamivudine 150 mg APO LMV 150 Back
Lamivudine 150 mg APO LMV 150
Lamivudine 150 mg APO LMV 150
Lamivudine
Imprint:
APO LMV 150
Strength:
150 mg
Color:
White
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Inc.
National Drug Code (NDC):
60505-3251
Inactive Ingredients:
lactose anhydrous
crospovidone
silicon dioxide colloidal
hypromelloses
hydroxypropyl cellulose
magnesium stearate
polyethylene glycol
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide